Indication
Prevention of breast cancer in high risk women
Prevention of breast cancer in high-risk women refers to primary risk-reduction strategies in females who have a significantly elevated probability of developing mammary malignancies compared to the general population. Read more about Prevention of breast cancer in high risk women
32 drugs 26 manufacturers
Drugs that treat it
Common Prevention of breast cancer in high risk women therapies.
RALOXIFENE HCL
RALOXIFENE HCL
RALOXIFENE HCL
RALOXIFENE HCL
TAMOXIFEN CITRATE
TAMOXIFEN CITRATE
TAMOXIFEN CITRATE
RALOXIFENE HCL
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonPrevention of breast cancer in high-risk women refers to primary risk-reduction strategies in females who have a significantly elevated probability of developing mammary malignancies compared to the general population.
This targeted demographic typically includes women with predisposing germline mutations, a strong family history of breast or ovarian cancer, prior high-risk histologic lesions such as atypical hyperplasia or lobular carcinoma in situ, or an elevated multi-factor risk score determined by validated predictive models.
Pathophysiologically, the state involves an altered mammary microenvironment driven by accumulated genetic instability, high-penetrance DNA-repair deficiencies, or prolonged estrogen-mediated proliferative signaling within glandular breast tissue.
Intervention in this setting seeks to disrupt oncogenic transformation and suppress early cellular progression before invasive malignant disease occurs.
- cancer.gov
Prevention of breast cancer in high-risk women refers to primary risk-reduction strategies in females who have a significantly elevated probability of developing mammary malignancies compared to the general population Pathophysiologically, the state involves an altered mammary microenvironment driven by accumulated genetic instability, high-penetrance DNA-repair deficiencies, or prolonged estrogen-mediated proliferative signaling within glandular breast tissue Intervention in this setting seeks ...
- nih.gov
Prevention of breast cancer in high-risk women refers to primary risk-reduction strategies in females who have a significantly elevated probability of developing mammary malignancies compared to the general population This targeted demographic typically includes women with predisposing germline mutations, a strong family history of breast or ovarian cancer, prior high-risk histologic lesions such as atypical hyperplasia or lobular carcinoma in situ, or an elevated multi-factor risk score determi...
- ucsfhealth.org
This targeted demographic typically includes women with predisposing germline mutations, a strong family history of breast or ovarian cancer, prior high-risk histologic lesions such as atypical hyperplasia or lobular carcinoma in situ, or an elevated multi-factor risk score determined by validated predictive models
- cancer.org
Pathophysiologically, the state involves an altered mammary microenvironment driven by accumulated genetic instability, high-penetrance DNA-repair deficiencies, or prolonged estrogen-mediated proliferative signaling within glandular breast tissue
- clinicaltrials.gov
Intervention in this setting seeks to disrupt oncogenic transformation and suppress early cellular progression before invasive malignant disease occurs
Personalize your experience
Follow Prevention of breast cancer in high risk women and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.